US81663L2007
US81663L2007
GeneDx Holdings Corp.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 427.539.000 | 305.450.000 | 40.0% |
| Cost of Revenue | 129.366.000 | 111.053.000 | 16.5% |
| Gross Profit | 298.173.000 | 194.397.000 | 53.4% |
| 311.250.000 | 217.610.000 | 43.0% | |
| Operating Income | -13.077.000 | -23.213.000 | 43.7% |
| Pretax Income | -21.137.000 | -52.629.000 | 59.8% |
| Net Income Common Stockholders | -21.021.000 | -52.286.000 | 59.8% |
| -- | -- | -- | |
| -- | -- | -- |